Can AI Cure Disease? with Ben Gmeiner (Director of Medical Data Strategy and Science)
Description
In this episode of Data Analytics Chat, we discuss the impact of AI on clinical research.
Ben Gmeiner, Director of Medical Data Strategy and Science at Novartis, a global pharmaceutical organisation, joins us.
We discuss AI's massive potential to revolutionise healthcare, enhance precision medicine, and improve clinical trials. Ben highlights the importance of integrating AI smoothly into existing workflows, ensuring data privacy, and overcoming regulatory challenges. We explore how AI can boost patient engagement and trial adherence and overcome the biggest barriers.
00:00 Introduction to Data Analytics Chat
00:30 Meet Ben Gmeiner, Director of Medical Data Strategy at Novartis
01:51 The Explosion of Health Data
02:45 AI's Transformative Impact on Clinical Research
04:13 Advancements in Clinical Trials with AI
10:23 Leveraging Health Data for AI Solutions
14:31 Challenges in AI Adoption in Healthcare
25:56 Regulatory Environment and AI Integration
31:39 Improving Patient Engagement with AI
34:04 Conclusion and Final Thoughts
Thank you for listening!
United States
